About
Ken Batchelor, PhD is a biotech R&D executive focused on drug discovery in cellular energetics, metabolic disease, kidney disease, neurodevelopmental disorders, and aging-related biology. He is Head of Research & Development at Pano Therapeutics and previously founded and led NovaTarg Therapeutics. Before NovaTarg, he spent a decade as SVP R&D at GlaxoSmithKline's North Carolina Center of Excellence for Drug Discovery.
Areas of interest
biotechdrug discoveryclinical developmentmitochondrial biologycellular energeticsagingmetabolic diseaseoncologyantiviral therapeuticskidney diseaseneurodevelopmental disorders